Table 2.
Comparison of serum cytokines and enzymes between the CB supplementation and the placebo treatments (mean ± 95% CI).
| Baseline | Post-Intake (Pre-Eccentric Exercise) | 24 h | 48 h | ‡p-Value | |||
|---|---|---|---|---|---|---|---|
| Main Effect | Interaction Effect | ||||||
| Group | Time | Group * Time | |||||
| IL-6 (pg/mL) | |||||||
| CB (n = 8) | 12.58 (−1.77, 26.94) |
15.47 (−12.34, 43.28) |
20.91 (−19.03, 60.86) |
24.88 (−6.13, 55.89) |
0.525 | 0.853 | 0.676 |
| Placebo (n = 8) | 28.28 (−11.61, 68.17) |
43.68 (−36.09, 123.45) |
17.96 (2.30, 33.61) |
13.48 (−1.17, 28.12) |
|||
| TNF-α (pg/mL) | |||||||
| CB (n = 8) | 60.37 (19.64, 101.11) |
47.38 (7.45, 87.30) |
65.88 (−7.77, 139.52) |
70.00 (7.97, 132.03) |
0.362 | 0.857 | 0.958 |
| Placebo (n = 8) | 105.50 (19.46, 191.54) |
93.75 (4.59, 182.91) |
99.00 (18.48, 179.52) |
101.25 (8.76, 193.74) |
|||
| LDH (U/L) | |||||||
| CB (n = 8) | 275.38 (237.09, 313.66) |
305.50 (258.65, 352.35) |
304.50 (261.93, 347.07) |
308.38 (261.35, 355.40) |
0.221 | 0.167 | 0.444 |
| Placebo (n = 8) | 268.00 (241.61, 294.39) |
257.00 (181.97, 332.03) |
324.88 (246.14, 403.61) |
270.38 (244.00, 296.75) |
|||
‡p-value was calculated by two-way repeated-measures ANOVA.